"The Latest ALS News: APRTX-003 is an experimental RNA therapy for ALS, targeting MMP 9 enzyme to reduce nerve cell damage. Preclinical trials ongoing."

New ALS research: https://bit.ly/4qg1JkM

APRTX-003 is an experimental RNA based therapy designed to reduce MMP 9, an enzyme associated with nerve cell damage.

#ALSNewsToday #ALSResearch #ALSScience #NeurodegenerativeDisease #RareDiseaseNews #Bionews